Balaji Amines Limited (NSE:BALAMINES)

Market Cap	47.66B
Revenue (ttm)	13.97B
Net Income (ttm)	1.58B
Shares Out	n/a
EPS (ttm)	48.62
PE Ratio	30.26
Forward PE	17.63
Dividend	11.00 (0.75%)
Ex-Dividend Date	Jul 4, 2024

Volume	41,762
Average Volume	69,713
Open	1,478.50
Previous Close	1,472.10
Day's Range	1,455.20 - 1,484.00
52-Week Range	1,127.55 - 2,549.75
Beta	0.58
RSI	62.57
Earnings Date	May 8, 2025

About Balaji Amines

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1988
• Employees: 1,084
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BALAMINES

Financial Performance

In 2024, Balaji Amines's revenue was 13.97 billion, a decrease of -14.89% compared to the previous year's 16.42 billion. Earnings were 1.58 billion, a decrease of -23.11%.